ArticleClinical and translational medicine2016

Novel paradigm for immunotherapy of ovarian cancer by engaging prophylactic immunity against hepatitis B virus.

Marek Malecki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.